Coppell Advisory Solutions LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1848433 COPPELL, TX

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$216,573

-$2,760,034 QoQ

Shares Held

436

-93.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#1,380

of 1,732 holders

Holding Since

Dec 2022

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Coppell Advisory Solutions LLC holds $1,491,155 across 13 Biotechnology names. VRTX ranks #4 (14.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TVTX	Travere Therapeutics, Inc.	12,304	$698,990
2	ANAB	Anaptysbio, Inc	3,638	$245,565
3	INCY	Incyte Corp	2,057	$233,181
4	VRTX	Vertex Pharmaceuticals Inc / Ma This page	436	$216,573
5	CORT	Corcept Therapeutics Inc	962	$83,645
6	ADMA	Adma Biologics, Inc.	670	$5,607
7	NTLA	Intellia Therapeutics, Inc.	134	$2,267
8	AGIO	Agios Pharmaceuticals, Inc.	59	$2,189

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$216,573	436	-93.5%	Shares	Sole	2026-08-14
2025-06-30	$2,976,607	6,686	+74.1%	Shares	Sole	2025-08-14
2025-03-31	$1,861,708	3,840	+693.4%	Shares	Sole	2025-05-16
2024-12-31	$194,906	484	+137.3%	Shares	Sole	2025-02-14
2024-09-30	$94,876	204	+121.7%	Shares	Sole	2024-11-14
2024-06-30	$43,122	92	-29.2%	Shares	Sole	2024-08-15
2023-12-31	$52,895	130	-19.3%	Shares	Sole	2024-02-14
2023-09-30	$55,986	161	+242.6%	Shares	Sole	2023-11-14
2023-06-30	$16,539	47	-70.8%	Shares	Sole	2023-08-17
2022-12-31	$46,493	161	—	Shares	Sole	2023-05-19
No filing history on record for this holder in this stock.